Estia Health (EHE) – NEUTRAL
|Date of Report||ASX||Price||Price Target||Analyst Recommendation|
|Date of Report|
|Sector : Health Care||52-Week Range: A$2.97 – 3.94|
|Industry: Healthcare Services||Market Cap: A$776.6m|
We rate EHE as a Neutral for the following reasons:
- Market-leading position in the industry.
- Ageing Australian population to provide positive tailwind.
- Ongoing brownfield and greenfield developments to drive earnings.
- Portfolio positioned in key geographic locations.
- New management is doing a good job of turning around the business.
- Solid balance sheet.
We see the following key risks to our investment thesis:
- Competitive risk from listed and unlisted providers will intensify following the industry’s deregulation.
- ACFI indexation freeze.
- New projects fail to deliver the earnings uplift.
- Falls in occupancy rates due to poor public image after being put on notice for poor facility conditions.
- Pricing pressures following the industry’s deregulation will put downward pressure on margins.
- Budget cuts to aged care will increase customers’ out-of-pocket expenses, thereby lowering demand.
- Churn risk as new government initiatives will allow customers to switch between providers, with EHE losing out on any unspent funds.
- Project development delays or cost blow-outs.
- Instability on the management level following Peter Arvanitis, Paul Gregerson and Pat Grier’s departure last year. Poor history of earnings downgrades.
EHE’s FY18 results came in line with management’s guidance. For FY18 vs. previous corresponding period (pcp), group revenue was up +4.1% and operating earnings (EBITDA) were also up +4.1%, with employee costs increasing +6.1% over the year.
Management was able to reduce Non-wage expenses over the year to ensure earnings growth kept up with revenue. The Company also provided FY19 guidance, expecting mid-single-digit EBITDA growth, all else being equal.
We maintain our Neutral recommendation. In our view, management is doing a good job in a tough trading environment, however we do not see some of the pressures abating in the short to medium term (e.g. wage pressure).
On a positive note, the Company’s strong balance sheet (gearing 0.7x EBITDA) provides room to fund growth initiatives.
- FY18 headline numbers. Group revenue was up +4.1% to $524.6m and operating earnings (EBITDA) over the year were also up +4.1% to $86.5m. However, due to higher depreciation, EBIT declined -6.2%. Over the period, the Company achieved average occupancy of 94.2%. The Company declared a fully franked final dividend of 8cps, which represented 100% of NPAT.
- Cost pressures persisting, although an industry wide issue. During the year, EHE’s employee benefits expenses were up +6.1% year on year, well ahead of revenue growth of +4.1%. Management was able to offset this by reducing ‘non-wage costs’ -1.9% year-on-year. Management noted staff cost inflation reflected the EBA (Enterprise Bargaining Agreement) increases and associated accrued leave uplifts.
- Solid balance sheet position. EHE solid balance sheet position gives the company flexibility to fund growth initiatives. As at 30 Jun-18, net debt was $63.8m, which equated to gearing ratio of 0.7x EBITDA (well below target range). Management has ample headroom to fund development and potential acquisitions. On the analysts call, management noted that they were looking at small scale acquisitions.
- Solid operating performance. In our view, management did a solid job over FY19 despite the clearly evident wage cost growth and freeze on ACFI (Aged Care Funding Instrument) indexation. Over the period, operating earnings (EBITDA) margin remained stable at 16.5%. However, management has pulled the efficiency lever in non-wage costs, which were down to $44.80 POBD (Per Occupied Bed Day) over the year (from $46.30 in pcp) or 16.8% of revenue (down from 17.8% in pcp). Importantly, management has invested in staff over the past 12 months, with staff to revenue ratio increasing to 65.8% (from 64.7% in pcp). Occupancy levels have also slightly ticked up during the year to 94.2% (from 93.5%)
- FY19 guidance. Management expects FY19 EBITDA to grow by “mid-single digit percentage” on its existing portfolio of homes, subject to no material changes in market or regulatory conditions. Management expects gearing to remain within its target range of 1.5x – 1.8x EBITDA. Further, management expects to distribute at least 70% of NPAT as fully franked dividends.
FY18 RESULTS SUMMARY…
Figure 1: EHE FY18 P&L
Figure 2: EHE FY18 key operating metrics
Figure 3: EHE Financial Summary
Source: BTIG, Company, Bloomberg
Estia Health Ltd (EHE) was formed in 2005 and is currently one of the largest residential aged care providers in Australia with 68 facilities, 5,910 operating places and more than 7,000 employees across Victoria, South Australia, New South Wales and Queensland.
Recommendation Rating Guide
|Recommendation Rating Guide||Total Return Expectations on a 12-mth view|
|Speculative Buy||Greater than +30%|
|Buy||Greater than +10%|
|Neutral||Greater than 0%|
|Sell||Less than -10%|
Reach Markets Disclaimer
Reach Markets Pty Ltd (ABN 36 145 312 232) is a Corporate Authorised Representative of Reach Financial Group Pty Ltd (ABN 17 090 611 680) who holds Australian Financial Services Licence (AFSL) 333297. Please refer to our Financial Services Guide or you can request for a copy to be sent to you, by emailing email@example.com.
Read our full disclaimer here >
This publication contains general securities advice. In preparing the advice, Reach Markets Australia has not taken into account the investment objectives, financial situation and particular needs of any particular person. Before making an investment decision on the basis of this advice, you need to consider, with or without the assistance of a securities adviser, whether the advice in this publication is appropriate in light of your particular investment needs, objectives and financial situation. Reach Markets Australia and its associates within the meaning of the Corporations Act may hold securities in the companies referred to in this publication. Reach Markets Australia does, and seeks to do, business with companies that are the subject of its research reports. Reach Markets Australia believes that the advice and information herein is accurate and reliable, but no warranties of accuracy, reliability or completeness are given (except insofar as liability under any statute cannot be excluded). No responsibility for any errors or omissions or any negligence is accepted by Reach Markets Australia or any of its directors, employees or agents. This publication must not be distributed to retail investors outside of Australia.
It is recommended that you seek independent advice and read the relevant Product Disclosure Statement before making a decision in relation to any investment. Any advice contained in this communication is general and has not taken into account the investment objectives, financial situation and particular needs of any particular person.
Banyan Tree Disclaimer
This document is provided by Banyan Tree Investment Group (ACN 611 390 615; AFSL 486279) (“Banyan Tree”).
The material in this document may contain general advice or recommendations which, while believed to be accurate at the time of publication, are not appropriate for all persons or accounts. This document does not purport to contain all the information that a prospective investor may require. The material contained in this document does not take into consideration an investor’s objectives, financial situation or needs. Before acting on the advice, investors should consider the appropriateness of the advice, having regard to the investor’s objectives, financial situation and needs. The material contained in this document is for sales purposes. The material contained in this document is for information purposes only and is not an offer, solicitation or recommendation with respect to the subscription for, purchase or sale of securities or financial products and neither or anything in it shall form the basis of any contract or commitment. This document should not be regarded by recipients as a substitute for the exercise of their own judgment and recipients should seek independent advice.
The material in this document has been obtained from sources believed to be true but neither Banyan Tree nor its associates make any recommendation or warranty concerning the accuracy, or reliability or completeness of the information or the performance of the companies referred to in this document. Past performance is not indicative of future performance. Any opinions and or recommendations expressed in this material are subject to change without notice and Banyan Tree is not under any obligation to update or keep current the information contained herein. References made to third parties are based on information believed to be reliable but are not guaranteed as being accurate.
Banyan Tree and its respective officers may have an interest in the securities or derivatives of any entities referred to in this material. Banyan Tree does, and seeks to do, business with companies that are the subject of its research reports. The analyst(s) hereby certify that all the views expressed in this report accurately reflect their personal views about the subject investment theme and/or company securities.
Although every attempt has been made to verify the accuracy of the information contained in the document, liability for any errors or omissions (except any statutory liability which cannot be excluded) is specifically excluded by Banyan Tree, its associates, officers, directors, employees and agents. Except for any liability which cannot be excluded, Banyan Tree, its directors, employees and agents accept no liability or responsibility for any loss or damage of any kind, direct or indirect, arising out of the use of all or any part of this material. Recipients of this document agree in advance that Banyan Tree is not liable to recipients in any matters whatsoever otherwise recipients should disregard, destroy or delete this document. All information is correct at the time of publication. Banyan Tree does not guarantee reliability and accuracy of the material contained in this document and is not liable for any unintentional errors in the document.
The securities of any company(ies) mentioned in this document may not be eligible for sale in all jurisdictions or to all categories of investors. This document is provided to the recipient only and is not to be distributed to third parties without the prior consent of Banyan Tree.
This document has been commissioned by Reach Markets Australia Pty Ltd and provided by Banyan Tree Investment Group (ACN 611 390 615; AFSL 486279) (“Banyan Tree”).